152 related articles for article (PubMed ID: 38709148)
1. Impact of sustained virologic response on glucose parameters among patients with chronic hepatitis C treated with direct-acting antivirals.
Benetti F; de Araújo A; de Maman Júnior I; Coelho Borges Cheinquer C; Herz Wolff F; Cheinquer H
Arch Endocrinol Metab; 2024 May; 68():e220480. PubMed ID: 38709148
[TBL] [Abstract][Full Text] [Related]
2. Improvement in Glycemic Control of Type 2 Diabetes After Successful Treatment of Hepatitis C Virus.
Hum J; Jou JH; Green PK; Berry K; Lundblad J; Hettinger BD; Chang M; Ioannou GN
Diabetes Care; 2017 Sep; 40(9):1173-1180. PubMed ID: 28659309
[TBL] [Abstract][Full Text] [Related]
3. Direct-acting antiviral agents decrease haemoglobin A1c level in patients with diabetes infected with hepatitis C virus: A systematic review & meta-analysis.
Lapumnuaypol K; Pisarcik D; Putthapiban P; Sukhumthammarat W; Wijarnpreecha K; Thongprayoon C; Ungprasert P
Indian J Med Res; 2020 Dec; 152(6):562-567. PubMed ID: 34145095
[TBL] [Abstract][Full Text] [Related]
4. Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents.
Ciancio A; Bosio R; Bo S; Pellegrini M; Sacco M; Vogliotti E; Fassio G; Bianco Mauthe Degerfeld AGF; Gallo M; Giordanino C; Terzi di Bergamo L; Ribaldone D; Bugianesi E; Smedile A; Rizzetto M; Saracco GM
J Med Virol; 2018 Feb; 90(2):320-327. PubMed ID: 28960353
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failure.
Lu M; Wu KH; Li J; Moorman AC; Spradling PR; Teshale EH; Boscarino JA; Daida YG; Schmidt MA; Rupp LB; Zhang T; Trudeau S; Gordon SC
J Viral Hepat; 2019 Oct; 26(10):1210-1217. PubMed ID: 31197910
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Hepatitis C Virus and Long-Term Effect on Glycemic Control.
Andres J; Barros M; Arutunian M; Zhao H
J Manag Care Spec Pharm; 2020 Jun; 26(6):775-781. PubMed ID: 32463777
[TBL] [Abstract][Full Text] [Related]
7. Five-year follow-up of sustained virological response with hepatitis C infection after direct-acting antiviral therapy: A single-center retrospective study.
Li M; Li Y; Zhang Y; Wang X; Lin C
Medicine (Baltimore); 2024 Feb; 103(7):e37212. PubMed ID: 38363923
[TBL] [Abstract][Full Text] [Related]
8. Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment.
Daniel KE; Saeian K; Rizvi S
J Viral Hepat; 2020 Feb; 27(2):195-204. PubMed ID: 31602715
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Chronic HCV Infection with the New Direct Acting Antivirals (DAA): First Report of a Real World Experience in Southern Brazil.
Cheinquer H; Sette H; Wolff FH; de Araujo A; Coelho-Borges S; Soares SRP; Barros MFA
Ann Hepatol; 2017; 16(5):727-733. PubMed ID: 28809742
[TBL] [Abstract][Full Text] [Related]
10. No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV.
Chaudhury CS; Sheehan J; Chairez C; Akoth E; Gross C; Silk R; Kattakuzhy S; Rosenthal E; Kottilil S; Masur H; Hadigan C
J Infect Dis; 2017 Dec; 217(1):47-50. PubMed ID: 29161418
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection.
Domínguez-Domínguez L; Bisbal O; Matarranz M; Lagarde M; Pinar Ó; Hernando A; Lumbreras C; Rubio R; Pulido F
Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):725-734. PubMed ID: 30687869
[TBL] [Abstract][Full Text] [Related]
12. Immunological recovery in T-cell activation after sustained virologic response among HIV positive and HIV negative chronic Hepatitis C patients.
Emmanuel B; El-Kamary SS; Magder LS; Stafford KA; Charurat ME; Poonia B; Chairez C; McLaughlin M; Hadigan C; Masur H; Kottilil S
Hepatol Int; 2019 May; 13(3):270-276. PubMed ID: 30835046
[TBL] [Abstract][Full Text] [Related]
13. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents.
Goñi Esarte S; Juanbeltz R; Zozaya JM; Úriz JI; Castilla J; Herrero JI
Gastroenterol Hepatol; 2020 May; 43(5):248-255. PubMed ID: 32192765
[TBL] [Abstract][Full Text] [Related]
14. Sustained virological response does not improve long-term glycaemic control in patients with type 2 diabetes and chronic hepatitis C.
Li J; Gordon SC; Rupp LB; Zhang T; Trudeau S; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Boscarino JA; Schmidt MA; Daida YG; Lu M;
Liver Int; 2019 Jun; 39(6):1027-1032. PubMed ID: 30570808
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Glycated Haemoglobin (HbA1c) Level in Type 2 Diabetic Chronic HCV Non-cirrhotic Treatment-Naïve Egyptian Patients Eradicated with Sofosbuvir Plus Daclatasvir.
Hussein HA; Allam AS; Moaty ASA
Curr Diabetes Rev; 2020; 16(2):165-170. PubMed ID: 31146663
[TBL] [Abstract][Full Text] [Related]
16. Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis.
Cacciola I; Russo G; Filomia R; Pitrone C; Caccamo G; Giandalia A; Alibrandi A; Stella Franzè M; Porcari S; Maimone S; Saitta C; Squadrito G; Raimondo G
Liver Int; 2021 Sep; 41(9):2059-2067. PubMed ID: 33894103
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life and fatigue in patients with chronic hepatitis C with therapy with direct-acting antivirals agents interferon-free.
Fagundes RN; Ferreira LEVVC; Pace FHL
PLoS One; 2020; 15(8):e0237005. PubMed ID: 32813740
[TBL] [Abstract][Full Text] [Related]
18. Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid.
Pham TT; Keast SL; Farmer KC; Thompson DM; Rathbun RC; Nesser NJ; Holderread BP; Skrepnek GH
J Manag Care Spec Pharm; 2018 Jul; 24(7):664-676. PubMed ID: 29952711
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study.
Choi GH; Jang ES; Kim YS; Lee YJ; Kim IH; Cho SB; Lee HC; Jang JW; Ki M; Choi HY; Baik D; Jeong SH
World J Gastroenterol; 2022 Aug; 28(30):4182-4200. PubMed ID: 36157119
[TBL] [Abstract][Full Text] [Related]
20. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
